Under the leadership of Notre Dame alumna, Dr. Patricia Curtin White (‘80), the Notre Dame Haiti Program is leading a medical mission team to Leogane, Haiti from June 18-25, 2016.
We are fighting to eliminate lymphatic filariasis, a mosquito-borne disease endemic in Haiti, by 2020
See how the program is expanding our work in Haiti.
Learn more about the life and passion of Fr. Thomas Streit, C.S.C., the founder and director of the Haiti Program.
Donate online today
Online giving for the Notre Dame Haiti Program is now available. Learn more.
A note from the director regarding the 2016 MDA in Haiti
The initial response to our program need to fund DEC (diethylcarbamize citrate) pills in support of the Spring 2016 MDA cycle in Haiti has been most heartening. The cost of the drug is a little less than three cents per person treated. The following table illustrates the impact you can have as we seek to treat over five million people:
|$100||Will purchase DEC pills for about 4,000 Haitians|
|$500||Will purchase DEC pills for about 20,000 Haitians|
|$1000||Will purchase DEC pills for about 40,000 Haitians|
|$5000||Will purchase DEC pills for about 200,000 Haitians|
On behalf of Fr. Tom and all of the team, thanks so much for your partnership and generosity!
Yours in Notre Dame...and for Haiti,
Almost half of the population in endemic areas of Haiti suffer from Lymphatic Filariasis.
Founded in 1993, the University of Notre Dame Haiti Program seeks to achieve the historic goal of eliminating Lymphatic Filariasis (LF) in Haiti by 2020. LF, a mosquito-borne disease that affects over 2 million Haitians, is the second leading cause of long-term disfigurement and disability worldwide. It can be eliminated in Haiti through mass drug administration and the distribution of co-fortified salt. The Haiti Program is partnering with the Haitian Ministry of Health, corporations, and non-governmental organizations to forever eliminate the disease in Haiti and alleviate the suffering of Haitians infected with LF. Our innovative work also provides an exportable model for LF elimination in other developing nations.
It’s a little more than an hour by car from the village of Léogâne to the Port-au-Prince office of Dr. Joseline Marhone, Haiti’s director of food and nutrition in the Ministry of Public Health and Population. It’s an instructive ride. The car is ventilated for passengers only by rolling down the windows, and then only when it’s moving, which isn’t as often as those accustomed to milder climates may like. Even in the city, the roads are winding, and the route seems devoid of right angles — indeed, of any angles at all. It’s a circuitous route to an unmarked destination. The office itself bears no markings of a government building. It’s literally a cargo container, roughly the size of a small semi-tractor trailer, with a hole cut in the side to accommodate a wall-mounted air conditioning unit, and a door affixed to a cut-out opening at the front.
At the least, it’s an unlikely place for Marhone to wax optimistic about her country’s prospects for dealing with lymphatic filariasis (LF), a cruel and debilitating mosquito-borne disease that has plagued Haiti for generations. Nevertheless, Marhone’s countenance, already bright, gleams when the subject is raised.